Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
CNS Drugs
Erschienen in: CNS Drugs 9/2005

01.09.2005 | Therapy in Practice

Guide to Anaesthetic Selection for Electroconvulsive Therapy

verfasst von: Dr Klaus J. Wagner, Oliver Möllenberg, Michael Rentrop, Christian Werner, Eberhard F. Kochs

Erschienen in: CNS Drugs | Ausgabe 9/2005

Einloggen, um Zugang zu erhalten

Abstract

Electroconvulsive therapy (ECT) is used in the treatment of severe psychiatric disorders. It involves the induction of a seizure for therapeutic purposes by the administration of a variable-frequency electrical stimulus via electrodes applied to the scalp. The original application of ECT in non-anaesthetised patients resulted in many traumatic effects and was replaced, in the early 1960s, with a modified ECT regimen that used anaesthesia with neuromuscular blockade. This remains the worldwide standard today. The development of modern ECT devices, with improved impulse modes, has also reduced the incidence of post-interventional cognitive adverse effects.
The variety of centrally-acting comedications administered and the cardiovascular effects occurring during the procedure make patients receiving ECT a challenge for the anaesthetist. The efficacy of ECT depends on the production of adequate seizures; however, the anaesthetic agents commonly used during ECT suppress the generation of convulsions. Therefore, the efficacy of ECT requires knowledge of anaesthetic precepts, understanding of the interaction between anaesthetic drugs and seizure activity, and awareness of the physiological effects of ECT as well as the treatment of those effects.
Successful and safe ECT depends on the correct choice of anaesthetic drugs for the individual patient, which have to be chosen with respect to the individual concomitant medication and pre-existing diseases. This review provides information for the optimal selection, set-up and practice of anaesthetic drug treatment in ECT.
Literatur
1.
Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev 2002; (2): CD000076
2.
Kalinowsky LB. History of convulsive therapy. Ann N Y Acad Sci 1986; 462: 1–4CrossRef
3.
Bennett AE. Preventing traumatic complications in convulsive shock therapy by curare. JAMA 1940; 114: 322–4CrossRef
4.
Abrams R. Electroconvulsive therapy. 3rd ed. New York: Oxford University Press, 1997
5.
Hermann RC, Dorwart RA, Hoover CW, et al. Variation in ECT use in the United States. Am J Psychiatry 1995; 152(6): 869–75PubMed
6.
Eranti SV, McLoughlin DM. Electroconvulsive therapy: state of the art. Br J Psychiatry 2003; 182: 8–9PubMedCrossRef
7.
Philpot M, Treloar A, Gormley N, et al. Barriers to the use of electroconvulsive therapy in the elderly: a European survey. Eur Psychiatry 2002; 17(1): 41–5PubMedCrossRef
8.
Abrams R. ECT for Parkinson’s disease. Am J Psychiatry 1989; 146(11): 1391–3PubMed
9.
Mittmann N, Herrmann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 1997; 46(3): 191–217PubMedCrossRef
10.
Prudic J, Sackeim HA. Refractory depression and electroconvulsive therapy in treatment strategies for refractory depression. Washington, DC: American Psychiatric Press, 1990
11.
Fink M. How does convulsive therapy work? Neuropsychopharmacology 1990; 3(2): 73–82PubMed
12.
13.
Sackeim HA, Decina P, Prohovnik I, et al. Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry 1983; 18(11): 1301–10PubMed
14.
Sackheim HA. Central issues regarding the mechanisms of action of electroconvulsive therapy: directions for future research. Psycopharmacol Bull 1994; 30(3): 281–308
15.
Jones RM, Knight PR. Cardiovascular and hormonal responses to electroconvulsive therapy. Modification of an exaggerated response in an hypertensive patient by beta-receptor blockade. Anaesthesia 1981; 36(8): 795–9
16.
Wells DG, Davies GG. Hemodynamic changes associated with electroconvulsive therapy. Anesth Analg 1987; 66(11): 1193–5PubMedCrossRef
17.
Fu W, Stool LA, White PF, et al. Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity. J Clin Anesth 1997; 9(8): 653–7PubMedCrossRef
18.
Elliot DL, Linz DH, Kane JA. Electroconvulsive therapy: pre-treatment medical evaluation. Arch Intern Med 1982; 142(5): 979–81PubMedCrossRef
19.
Woo D, Haverbusch M, Sekar P, et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004; 35(7): 1703–8PubMedCrossRef
20.
Webb MC, Coffey CE, Saunders WR, et al. Cardiovascular response to unilateral electroconvulsive therapy. Biol Psychiatry 1990; 28(9): 758–66PubMedCrossRef
21.
Zervas IM, Calev A, Jandorf L, et al. Blood pressure, memory, and electroconvulsive therapy. Convuls Ther 1993; 9(1): 14–22PubMed
22.
Saito S, Kadoi Y, Iriuchijima N, et al. Reduction of cerebral hyperemia with anti-hypertensive medication after electroconvulsive therapy. Can J Anaesth 2000; 47(8): 767–74PubMedCrossRef
23.
Saito S, Miyoshi S, Yoshikawa D, et al. Regional cerebral oxygen saturation during electroconvulsive therapy: monitoring by near-infrared spectrophotometry. Anesth Analg 1996; 83(4): 726–30PubMed
24.
Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg 2002; 94(5): 1351–64PubMedCrossRef
25.
Fink M. Convulsive therapy: theory and practice. New York (NY): Raven Press, 1979
26.
Kolano JE, Chhibber A, Calalang CC. Use of esmolol to control bleeding and heart rate during electroconvulsive therapy in a patient with an intracranial aneurysm. J Clin Anesth 1997; 9(6): 493–5PubMedCrossRef
27.
Bader GM, Silk KR, Dequardo JR, et al. Electroconvulsive therapy and intracranial aneurysm. Convuls Ther 1995; 11(2): 139–43PubMed
28.
Klapheke MM. Combining ECT and anitpsychotic agents: benefits and risks. Convuls Ther 1993; 9(4): 241–55PubMed
29.
Kellner CH, Pritchett JT, Beale MD, et al. Handbook of ECT. Washington, DC: American Psychiatric Press Inc., 1997
30.
Cardwell BA, Nakai B. Seizure activity in combined clozapine and ECT: a retrospective view. Convuls Ther 1995; 11(2): 110–3PubMed
31.
Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27(3): 373–9PubMedCrossRef
32.
Hedges D, Jeppson K, Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today (Barc) 2003; 39(7): 551–7CrossRef
33.
Bhatia SC, Bhatia SK, Gupta S. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia. J ECT 1998; 14(4): 280–3PubMedCrossRef
34.
Braga RJ, Petrides G. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J ECT 2005; 21(2): 75–83PubMedCrossRef
35.
Taylor D. Ziprasidone in the management of schizophrenia: the QT interval issue in context. CNS Drugs 2003; 17(6): 423–30PubMedCrossRef
36.
Freeman CP, Kendell RE. ECT: I. Patients’ experiences and attitudes. Br J Psychiatry 1980; 137: 8–16
37.
Naguib M, Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management. CNS Drugs 2002; 16(4): 229–47PubMedCrossRef
38.
Weiner RD. American Psychiatric Association committee on electroconvulsive therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. 2nd ed. Washington, DC: American Psychiatric Press, 2001
39.
Krystal AD, Watts BV, Weiner RD, et al. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. J ECT 1998; 14(1): 5–14PubMedCrossRef
40.
Kellner CH, Nixon DW, Bernstein HJ. ECT-drug interactions: a review. Psychopharmacol Bull 1991; 27(4): 595–609PubMed
41.
Lee D, Kenny M, Harrop-Griffiths W. Anaesthesia for electroconvulsive therapy: personnel and facilities. Anaesthesia 1996; 51(6): 583–4PubMedCrossRef
42.
Kober A, Schubert B, Bertalanffy P, et al. Capnography in non-tracheally intubated emergency patients as an additional tool in pulse oximetry for prehospital monitoring of respiration. Anesth Analg 2004; 98(1): 206–10PubMedCrossRef
43.
Swartz CM. Anesthesia for ECT. Convuls Ther 1993; 9(4): 301–16PubMed
44.
Bouckoms AJ, Welch CA, Drop LJ, et al. Atropine in electroconvulsive therapy. Convuls Ther 1989; 5(1): 48–55PubMed
45.
Kelway B, Simpson KH, Smith RJ, et al. Effects of atropine and glycopyrrolate on cognitive function following anaesthesia and electroconvulsive therapy (ECT). Int Clin Psychopharmacol 1986; 1(4): 296–302PubMedCrossRef
46.
Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991; 14(4): 803–43PubMed
47.
GainesIII GY, Rees DI. Electroconvulsive therapy and anesthetic considerations. Anesth Analg 1986; 65(12): 1345–56PubMedCrossRef
48.
Modica PA, Tempelhoff R, White PF. Pro- and anticonvulsant effects of anesthetics (Part II). Anesth Analg 1990; 70(4): 433–44PubMedCrossRef
49.
Bouckoms AJ, Welch CA, Drop LJ, et al. Methohexital dosage in electroconvulsive therapy. Convuls Ther 1989; 5(1): 44–7PubMed
50.
Fredman B, d’Etienne J, Smith I, et al. Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesth Analg 1994; 79(1): 75–9PubMed
51.
Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 1995; 81(3): 596–602PubMed
52.
Mokriski BK, Nagle SE, Papuchis GC, et al. Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium. J Clin Anesth 1992; 4(3): 208–12PubMedCrossRef
53.
Conca A, Germann R, Konig P. Etomidate vs thiopentone in electroconvulsive therapy: an interdisciplinary challenge for anesthesiology and psychiatry. Pharmacopsychiatry 2003; 36(3): 94–7PubMedCrossRef
54.
Saito S, Kadoi Y, Naro T, et al. The comparative effects of propofol verssus thiopental on middle cerebral artery blood flow velocity during electroconvulsive therapy. Anesth Analg 2000; 91(6): 1531–6PubMedCrossRef
55.
Fredman B, Husain MM, White PF. Anaesthesia for electroconvulsive therapy: use of propofol revisited. Eur J Anaesthesiol 1994; 11(5): 423–5PubMed
56.
Maisch E, Gratz I, Mani S, et al. Efficacy of electroconvulsive therapy after propofol and methohexital anesthesia. Convuls Ther 1994; 10(3): 212–9
57.
Mitchell P, Torda T, Hickie I, et al. Propofol as an anaesthetic agent for ECT: effect on outcome and length of course. Aust N Z J Psychiatry 1991; 25(2): 255–61PubMedCrossRef
58.
Izard P, Leclercq C, Ducasse JL, et al. Use of propofol in 1350 anesthetized patients for electroconvulsive therapy. Ann Fr Anesth Reanim 1991; 10(1): 16–20PubMedCrossRef
59.
Boey WK, Lai FO. Comparison of propofol and thiopentone as anaesthetic agents for electroconvulsive therapy. Anaesthesia 1990; 45(8): 623–8PubMedCrossRef
60.
Zaidi NA, Khan FA. Comparison of thiopentone sodium and propofol for electro convulsive therapy (ECT). J Pak Med Assoc 2000; 50(2): 60–3PubMed
61.
Loimer N, Hofmann P, Chaudhry HR. Midazolam shortens seizure duration following electroconvulsive therapy. J Psychiatr Res 1992; 26(2): 97–101PubMedCrossRef
62.
Saffer S, Berk M. Anesthetic induction for ECT with etomidate is associated with longer seizure duration than thiopentone. J ECT 1998; 14(2): 89–93PubMedCrossRef
63.
Reddy RV, Moorthy SS, Dierdorf SF, et al. Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol. Anesth Analg 1993; 77(5): 1008–11PubMedCrossRef
64.
Rasmussen KG, Jarvis MR, Zorumski CF. Ketamine anesthesia in electroconvulsive therapy. Convuls Ther 1996; 12(4): 217–23PubMed
65.
Tanaka N, Saito Y, Hikawa Y, et al. Effects of thiopental and sevoflurane on hemodynamics during anesthetic management of electroconvulsive therapy [in Japanese]. Masui 1997; 46(12): 1575–9PubMed
66.
Ishikawa T, Kawahara S, Saito T, et al. Anesthesia for electroconvulsive therapy during pregnancy: a case report [in Japanese]. Masui 2001; 50(9): 991–7PubMed
67.
Fredman B, Smith I, d’Etienne J, et al. Use of muscle relaxants for electroconvulsive therapy: how much is enough? Anesth Analg 1994; 78(1): 195–6PubMedCrossRef
68.
Van Den Berg AA, Honjol NM. Electroconvulsive therapy and intraocular pressure. Middle East J Anesthesiol 1998; 14(4): 249–58
69.
Dwersteg JF, Avery DH. Atracurium as a muscle relaxant for electroconvulsive therapy in a burned patient. Convuls Ther 1987; 3(1): 49–53PubMed
70.
Cheam EW, Critchley LA, Chui PT, et al. Low dose mivacurium is less effective than succinylcholine in electroconvulsive therapy. Can J Anaesth 1999; 46(1): 49–51PubMedCrossRef
71.
Lui PW, Ma JY, Chan KK. Modification of tonic-clonic convulsions by atracurium in multiple-monitored electroconvulsive therapy. J Clin Anesth 1993; 5(1): 16–21PubMedCrossRef
72.
Wulfson HD, Askanazi J, Finck AD. Propranolol prior to ECT associated with asystole. Anesthesiology 1984; 60(3): 255–6PubMedCrossRef
73.
Stoudemire A, Knos G, Gladson M, et al. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. J Clin Psychiatry 1990; 51(12): 508–12PubMed
74.
McCall WV, Shelp FE, Weiner RD, et al. Effects of labetalol on hemodynamics and seizure duration during ECT. Convuls Ther 1991; 7(1): 5–14PubMed
75.
McCall WV. Antihypertensive medications and ECT. Convuls Ther 1993; 9(4): 317–25PubMed
76.
Weinger MB, Partridge BL, Hauger R, et al. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analg 1991; 73(5): 556–62
77.
Wajima Z, Yoshikawa T, Ogura A, et al. Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity. Anesth Analg 2002; 95(2): 400–2PubMed
78.
Wells DG, Davies GG, Rosewarne F. Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine. Anaesth Intensive Care 1989; 17(1): 31–3PubMed
79.
Figiel GS, DeLeo B, Zorumski CF, et al. Combined use of labetalol and nifedipine in controlling the cardiovascular response from ECT. J Geriatr Psychiatry Neurol 1993; 6(1): 20–4PubMed
80.
Fu W, Stool LA, White PF, et al. Is oral clonidine effective in modifying the acute hemodynamic response during electroconvulsive therapy? Anesth Analg 1998; 86(5): 1127–30PubMed
81.
Blanch J, Martinez-Palli G, Navines R, et al. Comparative hemodynamic effects of urapidil and labetalol after electroconvulsive therapy. J ECT 2001; 17(4): 275–9PubMedCrossRef
82.
Nguyen TT, Chhibber AK, Lustik SJ, et al. Effect of methohexitone and propofol with or without alfentanil on seizure duration and recovery in electroconvulsive therapy. Br J Anaesth 1997; 79(6): 801–3PubMedCrossRef
83.
Dinwiddie SH, Isenberg KE. Combined alfentanil-methohexital anesthesia in electroconvulsive therapy. Convuls Ther 1995; 11(3): 170–6PubMed
84.
Andersen FA, Arsland D, Holst-Larsen H. Effects of combined methohexitone-remifentanil anaesthesia in electroconvulsive therapy. Acta Anaesthesiol Scand 2001; 45(7): 830–3PubMedCrossRef
Metadaten
Titel
Guide to Anaesthetic Selection for Electroconvulsive Therapy
verfasst von
Dr Klaus J. Wagner
Oliver Möllenberg
Michael Rentrop
Christian Werner
Eberhard F. Kochs
Publikationsdatum
01.09.2005
Verlag
Springer International Publishing
Erschienen in
CNS Drugs / Ausgabe 9/2005
Print ISSN: 1172-7047
Elektronische ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-200519090-00002

Weitere Artikel der Ausgabe 9/2005

CNS Drugs 9/2005 Zur Ausgabe

Therapy in Practice

Refractory Generalised Convulsive Status Epilepticus

Leading Article

Treatment of Parkinson’s Disease

Review Article

Fixed Drug Combinations for the Acute Treatment of Migraine

Adis Drug Evaluation

Modafinil

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise